Listening at Hearings at the FDA

maida.beth

Spread the love

Last month, I attended two days of hearings at the FDA campus in White Oak, MD.  The first day concerned two neuroscience molecules, gabapentin and paroxetine, both being evaluated for the treatment of menopausal vasomotor symptoms.